Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
10 Results Found
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Congressional committees have begun marking up their portions of a reconciliation bill to enact key pieces of President Trump’s agenda.
The 340B Drug Pricing Program
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs. Despite significant oversight from HRSA and the program’s proven record of decreasing government spending and expanding access to patient care, some want to scale it back or drastically reduce the benefits that eligible hospitals and their patients receive from the program.
Hospitals That Have Committed to the 340B Principles
To ensure good stewardship of the 340B program, hospitals participating in the program should structure hospital policies and practices to demonstrate their commitment. That demonstration of commitment includes sharing publicly how 340B savings are used to benefit the community, by, for example reaching more eligible patients and providing more comprehensive services for those in the community. The following hospitals have taken that commitment.
340B Advocacy Alliance Bulletin - October 6, 2023
Digital ad campaign highlights how the 340B program supports patients and communities .
AHA 340B Advocacy Alliance Bulletin - September 6, 2023
AHA 340B Advocacy Alliance Bulletin for September 6, 2023.
AHA 340B Advocacy Alliance Bulletin - May 19, 2023
The House Energy and Commerce Subcommittee on Health yesterday advanced a series of health care bills, and voted to pass and send to the full committee a bill that would impose additional reporting requirements on hospitals that participate in the 340B Drug Pricing Program.
AHA 340B Advocacy Alliance Bulletin: Attorneys general urge HHS to hold responsible drug manufacturers not providing 340B discounts
Attorneys general in 27 states and Washington, D.C., today
Urge Your Representatives to Sign onto ‘Dear Colleague’ Letter to Xavier Becerra, Asking Him to Protect 340B
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Xavier Becerra, the nominee for Department of Health and Human Services Secretary, asking him to take immediate action to ensure that manufacturers are prohibited from imposing unilateral changes to the 340B Drug Pricing Program that are in direct conflict with congressional intent and decades of written guidance.
AHA Submits Comments on CMS Guidance For Medicare Drug Price Negotiation Program
AHA shares feedback on the Centers for Medicare & Medicaid Services’ draft guidance on the Medicare drug price negotiation program.